title: Gene expression profiles in an hepatitis B virus transfected hepatoblastoma cell line and differentially regulated gene expression by interferon-alpha.
abstract: OBJECTIVE
  To study interactions between hepatitis B virus (HBV) and interferon-alpha in liver- derived cells.
  
  
  METHODS
  mRNAs were separately isolated from an HBV-transfected cell line (HepG(2)2.2.15) and its parental cell line (HepG(2)) pre- and post-interferon-alpha (IFN-alpha) treatment at 6, 24 and 48 h, followed by hybridization with a cDNA microarray filter dotted with 14 000 human genes. After hybridization and scanning of the arrays, the data were analyzed using ArrayGauge software. The microarray data were further verified by Northern blot analysis.
  
  
  RESULTS
  Compared to HepG(2) cells, 14 genes with known functions were down-regulated 3 to 12- magnitudes, while 7 genes were up-regulated 3-13 magnitudes in HepG(2)2.2.15 cells prior to IFN-alpha treatment. After interferon-alpha treatment, the expression of four genes (vascular endothelial growth factor, tyrosine phosphate 1E, serine protein with IGF-binding motif and one gene of clathrin light chain) in HepG(2)2.2.15 were up-regulated, while one gene encoding a GTP-binding protein, two genes of interferon-induced kinases and two proto-oncogenes were further down- regulated. Interestingly, under IFN-alpha treatment, a number of differentially regulated genes were new ESTs or genes with unknown functions.
  
  
  CONCLUSIONS
  The up-regulated genes in HepG(2)2.2.15 cell line suggested that under IFN-alpha treatment, these repressed cellular genes in HBV infected hepatocytes could be partially restored, while the down- regulated genes were most likely the cellular genes which could not be restored under interferon treatment. These down-regulated genes identified by microarray analysis could serve as new targets for anti-HBV drug development or for novel therapies.
authors.affiliation: Department of Molecular Virology, Shanghai Medical College, Fudan University Fudan, 138 Yi Xue Yuan Road, Shanghai 200032, China.
authors.forename: Xun
authors.initials: X
authors.lastname: Wang
authors.forename: Zheng-Hong
authors.initials: ZH
authors.lastname: Yuan
authors.forename: Ling-Jie
authors.initials: LJ
authors.lastname: Zheng
authors.forename: Feng
authors.initials: F
authors.lastname: Yu
authors.forename: Wei
authors.initials: W
authors.lastname: Xiong
authors.forename: Jiang-Xia
authors.initials: JX
authors.lastname: Liu
authors.forename: Gen-Xi
authors.initials: GX
authors.lastname: Hu
authors.forename: Yao
authors.initials: Y
authors.lastname: Li
mesh_terms: D000998:Antiviral Agents / Q000494:pharmacology*; D045744:Cell Line, Tumor / Q000502:physiology / Q000821:virology; D015967:Gene Expression Regulation, Viral / Q000187:drug effects*; D006515:Hepatitis B virus / Q000235:genetics*; D018197:Hepatoblastoma; D006801:Humans; D016898:Interferon-alpha / Q000494:pharmacology*; D008113:Liver Neoplasms; D020411:Oligonucleotide Array Sequence Analysis / Q000592:standards; D015203:Reproducibility of Results; D014162:Transfection
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha